je.st
news
Tag: biopharma
Array Biopharma Will Cut 20 Percent of Its Jobs
2013-08-08 16:40:32| Biotech - Topix.net
Drug developer Array BioPharma Inc. said Wednesday it will eliminate around 50 jobs, or 20 percent of its staff positions, after Amgen Inc. ended a partnership with Array on diabetes drugs.
Boulder-based Array BioPharma enters into potential $434M licensing agreement
2013-07-11 02:23:35| Biotech - Topix.net
Boulder-based Array BioPharma Inc. today announced it signed a drug discovery agreement that could land the locally based company up to $434 million if certain milestones are met.
Tags: agreement
potential
array
licensing
Cell Metric CLD(TM) Success in US Biopharma for Single Cell Cloning
2013-07-08 06:00:00| Industrial Newsroom - All News for Today
Solentim system offers substantial economic benefits<br /> <br /> Bournemouth, UK – Due to the significant time saving advantages of their Cell Metric™ systems, Solentim, the market-leading developer of innovative tools for shortening steps in the upstream cell line development workflow, have had their best quarter of sales revenues to date. This includes multiple shipments of Cell Metric systems to customers in the US and a repeat order from US biopharma. <br /> <br /> Cell Metric ...This story is related to the following:Vision SystemsSearch for suppliers of: Laboratory Equipment & Supplies |
Tags: single
cell
success
cloning
Sunshine Biopharma Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells
2013-06-05 07:10:25| drugdiscoveryonline News Articles
Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a new IND-Enabling study in which Adva-27a, the Company's flagship oncology drug candidate for breast cancer was found to be effective at killing Pancreatic Cancer Cells in vitro
Tags: drug
cells
cancer
candidate
Novozymes Biopharma to Showcase World Leading Products at CPhI China
2013-05-28 06:00:00| Industrial Newsroom - All News for Today
Innovative range of Hyaluronic Acid, recombinant albumin and enzymes for biocatalysis to be presented alongside insight into China investment<br /> <br /> NOTTINGHAM, UK – For the first time, Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, will showcase its biological-based ingredients and technologies at CPhI China. The company's Hyasis™, Recombumin® and biocatalysis products will feature at the pharmaceutical ingredients event, taking place in ...This story is related to the following:Materials and Material ProcessingGreen & CleanSearch for suppliers of: Enzymes |
Tags: world
products
china
leading
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »